Australia markets closed

Cidara Therapeutics Inc (20D.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
11.19+10.63 (+1,900.00%)
As of 08:04AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-36,270
-22,931
-33,584
-42,467
-72,111
-
Depreciation & amortisation
142
118
143
-1,230
1,050
-
Stock-based compensation
3,216
3,061
3,532
4,014
4,090
-
Change in working capital
14,011
-3,920
454
14,436
12,539
-
Accounts receivable
18,840
-10,413
-477
5,819
-11,165
-
Inventory
-7,269
-6,097
0
-
-
-
Accounts payable
843
8,886
-2,371
-
-
-
Other working capital
-18,612
-22,937
-28,591
-25,273
-54,597
-
Other non-cash items
723
1,240
982
15
21
-
Net cash provided by operating activities
-18,178
-22,432
-28,473
-25,232
-54,411
-
Cash flows from investing activities
Investments in property, plant and equipment
-434
-505
-118
-41
-186
-
Purchases of investments
-
-
-
-
-
0
Sales/maturities of investments
-
-
-
-
-
0
Net cash used for investing activities
-434
-505
-118
-41
-186
-
Cash flows from financing activities
Debt repayment
-50
0
-2,593
-4,444
-2,963
-
Common stock issued
-260
25,963
2,362
49,035
40,227
-
Common stock repurchased
-
-
-
-
-
0
Other financing activities
-
-
-720
-
-
-31
Net cash used provided by (used for) financing activities
-346
25,984
-951
44,597
37,278
-
Net change in cash
-18,958
3,047
-29,542
19,324
-17,319
-
Cash at beginning of period
47,976
32,731
62,273
42,949
60,268
-
Cash at end of period
29,018
35,778
32,731
62,273
42,949
-
Free cash flow
Operating cash flow
-18,178
-22,432
-28,473
-25,232
-54,411
-
Capital expenditure
-434
-505
-118
-41
-186
-
Free cash flow
-18,612
-22,937
-28,591
-25,273
-54,597
-